В. М. Мицура

476 total citations
31 papers, 70 citations indexed

About

В. М. Мицура is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, В. М. Мицура has authored 31 papers receiving a total of 70 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 16 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in В. М. Мицура's work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatitis B Virus Studies (10 papers). В. М. Мицура is often cited by papers focused on Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatitis B Virus Studies (10 papers). В. М. Мицура collaborates with scholars based in Belarus, United Kingdom and Denmark. В. М. Мицура's co-authors include Jens Lundgren, Lars Peters, Daniel Grint, Amanda Mocroft, Ole Kirk, Christoph Boesecke, Vincent Soriano, Jürgen K. Rockstroh, Antonella d’Arminio Monforte and Nelly Chentsova and has published in prestigious journals such as SHILAP Revista de lepidopterología, AIDS and Medicine.

In The Last Decade

В. М. Мицура

16 papers receiving 65 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
В. М. Мицура Belarus 5 50 42 30 15 9 31 70
F.P. Antonucci Italy 4 32 0.6× 36 0.9× 37 1.2× 10 0.7× 12 1.3× 10 77
T. Huleux France 4 45 0.9× 57 1.4× 32 1.1× 13 0.9× 5 0.6× 7 77
Nail Özgüneş Türkiye 5 55 1.1× 79 1.9× 31 1.0× 5 0.3× 8 0.9× 8 99
Tânia Reuter Brazil 7 35 0.7× 58 1.4× 41 1.4× 18 1.2× 10 1.1× 19 94
Anaïs Corma‐Gómez Spain 6 62 1.2× 69 1.6× 41 1.4× 6 0.4× 3 0.3× 26 113
Petra van Bentum Netherlands 4 32 0.6× 36 0.9× 16 0.5× 21 1.4× 5 0.6× 5 65
Bao-Chau Phung France 5 42 0.8× 62 1.5× 22 0.7× 4 0.3× 20 2.2× 6 76
Víctor J. Moreno Cuerda Spain 3 40 0.8× 31 0.7× 16 0.5× 8 0.5× 5 0.6× 10 64
Aneley Getahun Fiji 4 28 0.6× 36 0.9× 22 0.7× 3 0.2× 7 0.8× 5 60
S. Chadapaud France 4 28 0.6× 36 0.9× 12 0.4× 9 0.6× 10 1.1× 5 59

Countries citing papers authored by В. М. Мицура

Since Specialization
Citations

This map shows the geographic impact of В. М. Мицура's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. М. Мицура with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. М. Мицура more than expected).

Fields of papers citing papers by В. М. Мицура

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В. М. Мицура. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. М. Мицура. The network helps show where В. М. Мицура may publish in the future.

Co-authorship network of co-authors of В. М. Мицура

This figure shows the co-authorship network connecting the top 25 collaborators of В. М. Мицура. A scholar is included among the top collaborators of В. М. Мицура based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В. М. Мицура. В. М. Мицура is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Мицура, В. М., et al.. (2024). Yersiniosis with fever of unclear genesis. Health and Ecology Issues. 20(4). 144–148.
2.
Мицура, В. М., et al.. (2023). Viral-bacterial pneumonia in COVID-19: clinical and laboratory characteristics of patients and a spectrum of bacterial pathogens. Health and Ecology Issues. 20(2). 27–34. 1 indexed citations
3.
Мицура, В. М., et al.. (2022). Comparison of different DNA detection options for TTV, TTMDV, and TTMV viruses. Health and Ecology Issues. 19(1). 102–108.
4.
5.
Мицура, В. М., et al.. (2020). Issues of the diagnosis of hepatorenal syndrome in the practice of clinical medicine and pathoanatomy. Health and Ecology Issues. 49–55. 1 indexed citations
6.
Мицура, В. М., et al.. (2020). VIRAL COINFECTIONS IN PATIENTS WITH CHRONIC HEPATITIS B: THEIR PREVALENCE AND CLINICAL SIGNIFICANCE. SHILAP Revista de lepidopterología. 4(2). 171–176.
7.
Мицура, В. М., et al.. (2020). THE ROLE OF THE GUT-LIVER AXIS IN LIVER CIRRHOSIS PATHOGENESIS AND COMPLICATIONS. SHILAP Revista de lepidopterología. 4(2). 151–154.
8.
Мицура, В. М., et al.. (2019). PRIMARY DISABILITY DUE TO LIVER CIRROSIS IN THE GOMEL REGION. SHILAP Revista de lepidopterología. 3(2). 151–155. 1 indexed citations
9.
Мицура, В. М., et al.. (2018). <i>TORQUE TENO VIRUS</i>: PREVALENCE AND FEATURES OF PCR ANALYSIS. Health and Ecology Issues. 85–90. 2 indexed citations
10.
Мицура, В. М., et al.. (2018). RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS. Journal Infectology. 10(3). 77–83. 1 indexed citations
11.
Karpov, Igor, et al.. (2017). Antiviral therapy of chronic viral hepatitis C. 6–14. 1 indexed citations
12.
Мицура, В. М., et al.. (2016). INDIRECT MARKERS OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B AND C. Health and Ecology Issues. 24–29.
13.
Llibre, Josep M., Alessandro Cozzi‐Lepri, Court Pedersen, et al.. (2016). Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression. Medicine. 95(40). e5020–e5020. 1 indexed citations
14.
Мицура, В. М., et al.. (2014). [Clinical significance of interleukin-28B and RNAse L gene polymorphism determination in patients with chronic viral hepatitis C].. PubMed. 30–6. 1 indexed citations
15.
Borges, Álvaro H., Jens Lundgren, Annalisa Ridolfo, et al.. (2014). Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease. AIDS. 28(17). 2565–2571. 5 indexed citations
16.
Llibre, Josep M., Alessandro Cozzi‐Lepri, Court Pedersen, et al.. (2014). Long term effectiveness of once‐daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression. Journal of the International AIDS Society. 17(4S3). 19810–19810. 4 indexed citations
17.
18.
Rockstroh, Jürgen K., Daniel Grint, Christoph Boesecke, et al.. (2012). Increases in acute hepatitis C (HCV) incidence across Europe: which regions and patient groups are affected?. Journal of the International AIDS Society. 15(S4). 1–2. 8 indexed citations
19.
Мицура, В. М., et al.. (2006). [Antibodies to different virus antigens in patients with chronic hepatitis C].. PubMed. 57–61. 2 indexed citations
20.
Мицура, В. М., et al.. (2005). [Levels of some cytokines and antibodies to hepatitis C virus in patients with chronic hepatitis C].. PubMed. 103–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F.P. Antonucci Breakdown of academic impact, for papers by T. Huleux Breakdown of academic impact, for papers by Nail Özgüneş Breakdown of academic impact, for papers by Tânia Reuter Breakdown of academic impact, for papers by Anaïs Corma‐Gómez Breakdown of academic impact, for papers by Petra van Bentum Breakdown of academic impact, for papers by Bao-Chau Phung Breakdown of academic impact, for papers by Víctor J. Moreno Cuerda Breakdown of academic impact, for papers by Aneley Getahun Breakdown of academic impact, for papers by S. Chadapaud
Rankless by CCL
2026